About CQDM
Structure and Governance
Explore Advisory Committee
The role of the Explore Advisory Committee is to decide on the themes of calls for proposals and to select the projects that will be subject to an external scientific evaluation. This preselection will be based on innovation and the potential impact on biopharmaceutical research. The Explore Advisory Committee will make recommendations to the Board of Directors of CQDM about the final selection of projects The Explore Advisory Committee is composed of industry representatives, academia and a member of CQDM.
Chairman
 |
Julie Edwards Manager, Scientific Affairs,
Research and Development,
Boehringer Ingelheim (Canada) Ltd. |
Members
Sultan Ahmad
Director, External collaborations, CNS&Pain Innovative Medicines Montreal, Research and Development, AstraZeneca Canada
Kevin Canning
Manager, Medical Science Liaison Teams, Vaccines, Rheumatology, Hematology and Oncology, GlaxoSmithKline Inc. Canada
Max Fehlmann
President and Chief Executive Officer
Loren Grossman
Vice-President, Research and Development, Eli Lilly Canada
Luc Paquet
Vice-Dean Development and Partnerships, Professor and Director, Institut de Pharmacologie de Sherbrooke (IPS), Université de Sherbrooke
Patrice Roy
Director of R&D Quebec and Atlantic region,
Pfizer Canada
Steven Xanthoudakis
Director, Licensing and External Research - Canada, Merck Canada